The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single cell technologies have opened new opportunities to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option.
Omics technologies helps in comprehensive examination of genome biology (Genomics), proteins (Proteomics) and RNA molecules (Transcriptomics) which in turn are used for drug discovery and development. Thus, these single cell omics prospects are much anticipated to revolutionise our adequacy to understand the magnitude of omics diversity occurring in our biological systems.
MarketsandMarkets is delighted to announce its 2nd Annual Single-Cell Omics Conference scheduled to be held on 9th – 10th October 2023 in London, UK. The conference will assimilate diverse sessions on a board prospective of novel research and development in the field of multi-omics research. The event encompasses the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe and provides the platform to share the knowledge with academic peers and present their research papers and reports.
London
